The Nasdaq and Toronto Stock Exchange have approved changes to Correvio Pharma Corp.'s stock ticker symbols.

Effective May 17, the company's common shares will start trading under the trading symbol CORV on both the Nasdaq and TSX, and the prior trading symbols of CRME on Nasdaq and COM on TSX will no longer be active.

Correvio was previously known as Cardiome Pharma Corp. It is a specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients.